326 related articles for article (PubMed ID: 8613355)
1. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses.
Okahashi N; Yamamoto M; Vancott JL; Chatfield SN; Roberts M; Bluethmann H; Hiroi T; Kiyono H; McGhee JR
Infect Immun; 1996 May; 64(5):1516-25. PubMed ID: 8613355
[TBL] [Abstract][Full Text] [Related]
2. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunity: regulation by helper T cells and a novel method for detection.
Jackson RJ; Marinaro M; VanCott JL; Yamamoto M; Okahashi N; Fujihashi K; Kiyono H; Chatfield SN; McGhee JR
J Biotechnol; 1996 Jan; 44(1-3):209-16. PubMed ID: 8717406
[TBL] [Abstract][Full Text] [Related]
4. The role of Th1 and Th2 cells for mucosal IgA responses.
Yamamoto M; Vancott JL; Okahashi N; Marinaro M; Kiyono H; Fujihashi K; Jackson RJ; Chatfield SN; Bluethmann H; McGhee JR
Ann N Y Acad Sci; 1996 Feb; 778():64-71. PubMed ID: 8611017
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.
Takahashi I; Marinaro M; Kiyono H; Jackson RJ; Nakagawa I; Fujihashi K; Hamada S; Clements JD; Bost KL; McGhee JR
J Infect Dis; 1996 Mar; 173(3):627-35. PubMed ID: 8627026
[TBL] [Abstract][Full Text] [Related]
6. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses.
Marinaro M; Boyaka PN; Finkelman FD; Kiyono H; Jackson RJ; Jirillo E; McGhee JR
J Exp Med; 1997 Feb; 185(3):415-27. PubMed ID: 9053442
[TBL] [Abstract][Full Text] [Related]
7. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR
J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461
[TBL] [Abstract][Full Text] [Related]
8. Impaired mucosal immune responses in interleukin 4-targeted mice.
Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N
J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021
[TBL] [Abstract][Full Text] [Related]
9. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
[TBL] [Abstract][Full Text] [Related]
10. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles for Peyer's patch B cells for induction of antigen-specific IgA antibody responses in mice administered oral recombinant Salmonella.
Hashizume-Takizawa T; Shibata N; Kurashima Y; Kiyono H; Kurita-Ochiai T; Fujihashi K
Int Immunol; 2019 Jul; 31(8):531-541. PubMed ID: 30868152
[TBL] [Abstract][Full Text] [Related]
12. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
Gärdby E; Lycke NY
Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella.
VanCott JL; Staats HF; Pascual DW; Roberts M; Chatfield SN; Yamamoto M; Coste M; Carter PB; Kiyono H; McGhee JR
J Immunol; 1996 Feb; 156(4):1504-14. PubMed ID: 8568254
[TBL] [Abstract][Full Text] [Related]
14. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin.
Xu-Amano J; Jackson RJ; Fujihashi K; Kiyono H; Staats HF; McGhee JR
Vaccine; 1994 Aug; 12(10):903-11. PubMed ID: 7975832
[TBL] [Abstract][Full Text] [Related]
15. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.
Yamamoto S; Kiyono H; Yamamoto M; Imaoka K; Fujihashi K; Van Ginkel FW; Noda M; Takeda Y; McGhee JR
Proc Natl Acad Sci U S A; 1997 May; 94(10):5267-72. PubMed ID: 9144226
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin-4 (IL-4) and IL-10 in serum immunoglobulin G antibody responses following mucosal or systemic reovirus infection.
Mathers AR; Cuff CF
J Virol; 2004 Apr; 78(7):3352-60. PubMed ID: 15016857
[TBL] [Abstract][Full Text] [Related]
17. Peyer's patches are required for intestinal immunoglobulin A responses to Salmonella spp.
Hashizume T; Togawa A; Nochi T; Igarashi O; Kweon MN; Kiyono H; Yamamoto M
Infect Immun; 2008 Mar; 76(3):927-34. PubMed ID: 18086815
[TBL] [Abstract][Full Text] [Related]
18. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.
Marinaro M; Boyaka PN; Jackson RJ; Finkelman FD; Kiyono H; Jirillo E; McGhee JR
J Immunol; 1999 Jan; 162(1):114-21. PubMed ID: 9886376
[TBL] [Abstract][Full Text] [Related]
19. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice.
Cai Y; Kurita-Ochiai T; Kobayashi R; Hashizume T; Yamamoto M
J Oral Sci; 2013; 55(2):107-14. PubMed ID: 23748449
[TBL] [Abstract][Full Text] [Related]
20. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
